The London Stock Exchange has warned that as many as 200 companies could consider moving their listings from the UK to the US under a worst-case scenario, according to a scenario assessment examining potential listing structure shifts. The warning highlights concerns that such a migration could create an estimated £2 billion revenue gap for the UK Treasury. The risk stems from the UK's 0.5% stamp duty on share purchases, which critics argue creates a structural disadvantage compared to US markets where no equivalent charge applies, while deeper US capital markets offer higher valuations and stronger investor demand for growth companies. The assessment reflects intensifying pressure on London's ability to retain major public companies and financial technology firms as trading activity and investor attention increasingly gravitate toward American exchanges.
The LSE's scenario assessment examines what could happen if more companies shift their listing structures away from London. The risk covers both blue-chip companies and smaller fintech firms. The assessment addresses not only formal delisting but also the migration of trading activity, liquidity and investor attention toward US markets. A company does not need to leave the UK completely for London to lose influence—if investors begin treating a US listing as the main market, trading volumes can migrate, valuation benchmarks can shift and the UK line can become less relevant.
UK Stamp Duty Creates 0.5% Trading Cost Disadvantage
The UK imposes a 0.5% stamp duty on share purchases, while US-listed equities face no equivalent charge. Market participants have argued that the levy makes UK-listed shares less attractive by raising trading costs, reducing liquidity and creating a structural disadvantage when companies compare listing venues. The government faces a trade-off between preserving tax revenue and maintaining London's competitiveness as a listing venue. Scrapping stamp duty could make UK equities more competitive but would remove a significant source of tax revenue, while keeping the levy preserves near-term receipts but may encourage more activity to move overseas.
Wise and AstraZeneca Shifted US Market Presence
Wise, one of the UK's fintech companies, moved its primary listing to the US while retaining a London presence. The decision was viewed as a blow to London's technology listing ambitions, particularly because fintech has been one of the UK's strongest growth sectors. AstraZeneca retained its UK listing and headquarters but strengthened its New York market presence, raising concerns that other major UK-listed companies could follow similar routes. These cases demonstrate how listing migration can happen gradually, with companies maintaining UK identity while allowing liquidity and valuation attention to move toward New York.
London Faces Competition from Deeper US Capital Markets
London is competing against deeper US capital markets, higher valuations and stronger investor demand for growth companies. For technology, fintech and life sciences firms, the US offers access to a larger base of specialist investors and more liquid trading. The LSE's scenario does not indicate 200 companies are preparing to leave immediately—it reflects the scale of risk if current pressures continue. The LSE previously opened private market access to retail investors via Crowdcube and debuted a blockchain platform for private funds. For companies, the decision increasingly centers on practical factors: if the US offers better trading depth, stronger valuations and no stamp duty on share purchases, boards may find it harder to defend London as the main market.
FAQ
What did the London Stock Exchange warn about company listings?
The London Stock Exchange warned that as many as 200 companies could consider moving their listings from the UK to the US under a worst-case scenario, according to a scenario assessment. The warning indicates such a migration could create an estimated £2 billion revenue gap for the UK Treasury.
Why does UK stamp duty affect London's listing competitiveness?
The UK imposes a 0.5% stamp duty on share purchases while US-listed equities face no equivalent charge. Critics argue this levy raises trading costs, reduces liquidity and creates a structural disadvantage for UK-listed shares when companies compare listing venues, particularly for companies needing deep pools of capital and active institutional trading.
Which major companies shifted their market presence toward the US?
Wise moved its primary listing to the US while retaining a London presence, viewed as a blow to London's technology listing ambitions. AstraZeneca retained its UK listing and headquarters but strengthened its New York market presence, demonstrating how companies can gradually shift liquidity and investor attention toward US markets.
